CHLORDIAZEPOXIDE HYDROCHLORIDE capsule

Šalis: Jungtinės Valstijos

kalba: anglų

Šaltinis: NLM (National Library of Medicine)

Veiklioji medžiaga:

CHLORDIAZEPOXIDE HYDROCHLORIDE (UNII: MFM6K1XWDK) (CHLORDIAZEPOXIDE - UNII:6RZ6XEZ3CR)

Prieinama:

TYA Pharmaceuticals

INN (Tarptautinis Pavadinimas):

CHLORDIAZEPOXIDE HYDROCHLORIDE

Sudėtis:

CHLORDIAZEPOXIDE HYDROCHLORIDE 25 mg

Vartojimo būdas:

ORAL

Recepto tipas:

PRESCRIPTION DRUG

Terapinės indikacijos:

Chlordiazepoxide HCl capsules USP are indicated for the management of anxiety disorders or for the short term relief of symptoms of anxiety, withdrawal symptoms of acute alcoholism, and preoperative apprehension and anxiety. Anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic. The effectiveness of chlordiazepoxide HCl capsules USP in long term use, that is, more than 4 months, has not been assessed by systematic clinical studies. The physician should periodically reassess the usefulness of the drug for the individual patient. Chlordiazepoxide HCl capsules are contraindicated in patients with known hypersensitivity to the drug. Chlordiazepoxide hydrochloride capsules are classified by the Drug Enforcement Administration as a Schedule IV controlled substance. Withdrawal symptoms, similar in character to those noted with barbiturates and alcohol (convulsions, tremor, abdominal and muscle cramps, vomiting and sweating), have occurred following abrup

Produkto santrauka:

NDC:64725-0159-1 in a BOTTLE of 100 CAPSULES

Autorizacija statusas:

Abbreviated New Drug Application

Prekės savybės

CHLORDIAZEPOXIDE HYDROCHLORIDE- CHLORDIAZEPOXIDE HYDROCHLORIDE CAPSULE
TYA PHARMACEUTICALS
----------
CHLORDIAZEPOXIDE HYDROCHLORIDE CAPSULES USP CIV
RX ONLY
DESCRIPTION
Chlordiazepoxide hydrochloride is the prototype for the benzodiazepine
compounds. It is a versatile
therapeutic agent of proven value for the relief of anxiety.
Chlordiazepoxide hydrochloride is among
the safer of the effective psychopharmacologic compounds available, as
demonstrated by extensive
clinical evidence.
Chlordiazepoxide hydrochloride is 7-chloro-2- (methylamino)-5-phenyl-3
-1, 4-benzodiazepine 4-
oxide hydrochloride. A white to practically white crystalline
substance, it is soluble in water. It is
unstable in solution and the powder must be protected from light. The
structural formula is: _H_
C H CLN O • HCL MOLECULAR WEIG HT: 336.22
C H ClN O • HCl M.W. 336.22
Each capsule, for oral administration, contains either 5 mg, 10 mg or
25 mg of chlordiazepoxide
hydrochloride USP and has the following inactive ingredients:
anhydrous lactose, D&C yellow no. 10,
FD&C blue no. 1, FD&C blue no. 1 aluminum lake, gelatin, hydrogenated
vegetable oil,
microcrystalline cellulose, pharmaceutical glaze, and titanium
dioxide. The 5 mg and 25 mg also
contains D&C yellow no. 10 aluminum lake, FD&C blue no. 2 aluminum
lake, FD&C red no. 40
aluminum lake, propylene glycol, and synthetic black iron oxide. In
addition, the 5 mg contains D&C red
no. 33 and the 10 mg also contains butyl paraben, edetate calcium
disodium, dimethyl polysiloxane,
ethylene glycol monoethyl ether, FD&C red no. 40, methyl paraben,
propyl paraben, sodium, sodium
lauryl sulfate, sodium propionate, and soya lecithin.
CLINICAL PHARMACOLOGY
Chlordiazepoxide HCl has antianxiety, sedative, appetite-stimulating
and weak analgesic actions. The
precise mechanism of action is not known. The drug blocks EEG arousal
from stimulation of the brain
stem reticular formation. It takes several hours for peak blood levels
to be reached and the half-life of
the drug is between 24 and 48 hours. After